Cargando…

T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease

Background: T-lymphocyte subsets reflect patients' immune status and are associated with adverse outcomes in various diseases. However, the association between T-lymphocyte subsets and major infection and renal outcome in chronic kidney disease (CKD) patients has not been well-addressed. Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jiachuan, Qiao, Yu, Yu, Zhikai, Huang, Yinghui, Yang, Ke, He, Ting, Zhao, Jinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458643/
https://www.ncbi.nlm.nih.gov/pubmed/34568395
http://dx.doi.org/10.3389/fmed.2021.742419
_version_ 1784571337697656832
author Xiong, Jiachuan
Qiao, Yu
Yu, Zhikai
Huang, Yinghui
Yang, Ke
He, Ting
Zhao, Jinghong
author_facet Xiong, Jiachuan
Qiao, Yu
Yu, Zhikai
Huang, Yinghui
Yang, Ke
He, Ting
Zhao, Jinghong
author_sort Xiong, Jiachuan
collection PubMed
description Background: T-lymphocyte subsets reflect patients' immune status and are associated with adverse outcomes in various diseases. However, the association between T-lymphocyte subsets and major infection and renal outcome in chronic kidney disease (CKD) patients has not been well-addressed. Methods: Patients diagnosed with stage 3–5 of non-dialysis CKD were recruited, and healthy subjects were selected as the controls. T-lymphocyte subsets (CD3(+), CD4(+), CD8(+)) were detected by flow cytometry, and the CD4(+)/CD8(+) T cell ratio was then calculated. Patients were divided into the normal-level group and the low-level group according to the clinical reference value. The primary outcomes were the major infection and renal outcome. Results: A total of 410 CKD patients were enrolled; the average age was 47.25 years. Compared to the healthy controls, the level of CD3(+), CD4(+), CD8(+) T cells, and the CD4(+)/CD8(+) T cell ratio were significantly decreased in CKD patients (p < 0.05). During the median follow-up of 2.56 (quartile interval 1.24–3.46) years, major infections occurred in 15.10% of the CKD patients. The incidence of infection was significantly higher in the low-level group of CD3(+), CD4(+) T cells, and CD4(+)/CD8(+) T cell ratio compared with the normal level groups. Kaplan-Meier analysis showed that the lower level of CD3(+), CD4(+) T cells, and CD4(+)/CD8(+)T cell ratio is associated with a greater risk of infection. Cox regression analysis further confirmed that low CD3(+), CD4(+) T cells, and CD4(+)/CD8(+) T cell ratio were independent risk factors of infection in CKD patients. Moreover, during the follow-up, renal events occurred in 37.50% of patients. Kaplan-Meier analysis indicated that low levels of CD3(+), CD4(+), and CD8(+) T cells are significantly associated with renal outcome in CKD patients. Cox regression analysis showed that low level of CD3(+) T cells (HR = 2.407, 95% CI: 1.664–3.482, p < 0.001), CD4(+) T cells (HR = 2.397, 95% CI: 1.633–3.518, p < 0.001) and CD8(+) T cells (HR = 2.416, 95% CI: 1.476–3.955, p < 0.001) were independent risk factors for renal outcome after multivariable-adjusted. Conclusion: CKD patients had a defect in T-lymphocyte subpopulation. T-lymphocyte subsets were closely associated with infection and renal outcome in CKD patients. Suggesting T-lymphocyte subsets are independent predictors of infection and renal outcome in CKD patients.
format Online
Article
Text
id pubmed-8458643
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84586432021-09-24 T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease Xiong, Jiachuan Qiao, Yu Yu, Zhikai Huang, Yinghui Yang, Ke He, Ting Zhao, Jinghong Front Med (Lausanne) Medicine Background: T-lymphocyte subsets reflect patients' immune status and are associated with adverse outcomes in various diseases. However, the association between T-lymphocyte subsets and major infection and renal outcome in chronic kidney disease (CKD) patients has not been well-addressed. Methods: Patients diagnosed with stage 3–5 of non-dialysis CKD were recruited, and healthy subjects were selected as the controls. T-lymphocyte subsets (CD3(+), CD4(+), CD8(+)) were detected by flow cytometry, and the CD4(+)/CD8(+) T cell ratio was then calculated. Patients were divided into the normal-level group and the low-level group according to the clinical reference value. The primary outcomes were the major infection and renal outcome. Results: A total of 410 CKD patients were enrolled; the average age was 47.25 years. Compared to the healthy controls, the level of CD3(+), CD4(+), CD8(+) T cells, and the CD4(+)/CD8(+) T cell ratio were significantly decreased in CKD patients (p < 0.05). During the median follow-up of 2.56 (quartile interval 1.24–3.46) years, major infections occurred in 15.10% of the CKD patients. The incidence of infection was significantly higher in the low-level group of CD3(+), CD4(+) T cells, and CD4(+)/CD8(+) T cell ratio compared with the normal level groups. Kaplan-Meier analysis showed that the lower level of CD3(+), CD4(+) T cells, and CD4(+)/CD8(+)T cell ratio is associated with a greater risk of infection. Cox regression analysis further confirmed that low CD3(+), CD4(+) T cells, and CD4(+)/CD8(+) T cell ratio were independent risk factors of infection in CKD patients. Moreover, during the follow-up, renal events occurred in 37.50% of patients. Kaplan-Meier analysis indicated that low levels of CD3(+), CD4(+), and CD8(+) T cells are significantly associated with renal outcome in CKD patients. Cox regression analysis showed that low level of CD3(+) T cells (HR = 2.407, 95% CI: 1.664–3.482, p < 0.001), CD4(+) T cells (HR = 2.397, 95% CI: 1.633–3.518, p < 0.001) and CD8(+) T cells (HR = 2.416, 95% CI: 1.476–3.955, p < 0.001) were independent risk factors for renal outcome after multivariable-adjusted. Conclusion: CKD patients had a defect in T-lymphocyte subpopulation. T-lymphocyte subsets were closely associated with infection and renal outcome in CKD patients. Suggesting T-lymphocyte subsets are independent predictors of infection and renal outcome in CKD patients. Frontiers Media S.A. 2021-09-09 /pmc/articles/PMC8458643/ /pubmed/34568395 http://dx.doi.org/10.3389/fmed.2021.742419 Text en Copyright © 2021 Xiong, Qiao, Yu, Huang, Yang, He and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Xiong, Jiachuan
Qiao, Yu
Yu, Zhikai
Huang, Yinghui
Yang, Ke
He, Ting
Zhao, Jinghong
T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
title T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
title_full T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
title_fullStr T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
title_full_unstemmed T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
title_short T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
title_sort t-lymphocyte subsets alteration, infection and renal outcome in advanced chronic kidney disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458643/
https://www.ncbi.nlm.nih.gov/pubmed/34568395
http://dx.doi.org/10.3389/fmed.2021.742419
work_keys_str_mv AT xiongjiachuan tlymphocytesubsetsalterationinfectionandrenaloutcomeinadvancedchronickidneydisease
AT qiaoyu tlymphocytesubsetsalterationinfectionandrenaloutcomeinadvancedchronickidneydisease
AT yuzhikai tlymphocytesubsetsalterationinfectionandrenaloutcomeinadvancedchronickidneydisease
AT huangyinghui tlymphocytesubsetsalterationinfectionandrenaloutcomeinadvancedchronickidneydisease
AT yangke tlymphocytesubsetsalterationinfectionandrenaloutcomeinadvancedchronickidneydisease
AT heting tlymphocytesubsetsalterationinfectionandrenaloutcomeinadvancedchronickidneydisease
AT zhaojinghong tlymphocytesubsetsalterationinfectionandrenaloutcomeinadvancedchronickidneydisease